Jason Gardner - 14 Sep 2021 Form 4 Insider Report for Magenta Therapeutics, Inc. (DNTH)

Role
President and Chief Executive Officer, Director
Signature
/s/ Jason Gardner
Issuer symbol
DNTH
Transactions as of
14 Sep 2021
Net transactions value
$0
Form type
4
Filing time
16 Sep 2021, 19:40:31 UTC
Previous filing
03 Aug 2021
Next filing
20 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGTA Common Stock Award $0 +50,000 +20% $0.000000 301,212 14 Sep 2021 Direct F1
holding MGTA Common Stock 292,990 14 Sep 2021 By J.P. Gardner Irrevocable Trust
holding MGTA Common Stock 359,092 14 Sep 2021 By P.S. Gardner Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 11, 2021, the reporting person was granted 100,000 restricted stock units. The restricted stock units vest in two equal installments subject to the achievement of certain performance milestones related to the issuer's business plans. The first performance milestone was achieved, resulting in vesting of 50,000 restricted stock units and the corresponding issuance of 50,000 shares of issuer common stock.

Remarks:

President and Chief Executive Officer